aspect of
atenolol)
→
ReceivesAction
→
maintained in long-term follow-up studies
| Typicality: | 0.250 |
| Saliency: | 0.000 |
| without placebo control | 3 | other |
| effect → be maintained in → long-term follow-up studies | 3 |
| negative | neutral | positive |
| 0.007 | 0.760 | 0.233 |
| Raw frequency | 3 |
| Normalized frequency | 0.000 |
| Modifier score | 0.500 |
| Perplexity | 34.111 |